Loading…
A-25 Transcranial Photobiomodulation Treatment Effects In Former Athletes With Repetitive Head Hits
Abstract Purpose: Psychiatric symptoms, sleep disruption, reaction time, and fine motor coordination are associated with repetitive head hits. Transcranial photobiomodulation (tPBM) has been proposed as a non-invasive treatment for post-head injury symptoms. This proof-of-concept study begins to add...
Saved in:
Published in: | Archives of clinical neuropsychology 2022-07, Vol.37 (5), p.1066-1066 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Abstract
Purpose: Psychiatric symptoms, sleep disruption, reaction time, and fine motor coordination are associated with repetitive head hits. Transcranial photobiomodulation (tPBM) has been proposed as a non-invasive treatment for post-head injury symptoms. This proof-of-concept study begins to address tPBM’s potential utility in the neurorehabilitation of athletes with repetitive head hits. Methods: Study participants included 49 former male and female athletes (Mage = 45.90 years; SD = 14.45) with a history of repetitive head hits. Inclusion criteria were: aged 18–65 years and a self-reported history of concussive and/or repetitive sub-concussive events. We conducted a non-randomized study design wherein participants received active tPBM treatment for 8 weeks. At pre- and post-treatment timepoints, self-report questionnaires for depression (CES-D), posttraumatic stress (PCL-5), adjustment (MPAI-4), and sleep quality (PSQI) were obtained, as were assessments of simple reaction time, grip strength, and hand dexterity (Grooved Pegboard). Paired t-tests analyzed pre- and post-treatment effects. Results: Following tPBM treatment, study participants demonstrated statistically significant reductions in self-reported depression (t = 4.54, p |
---|---|
ISSN: | 1873-5843 1873-5843 |
DOI: | 10.1093/arclin/acac32.25 |